MTOR and endometrial cancer: Propofol decreased apoptosis and increased cancer cell viability in cervical and endometrium cancer via blocking HSp70 ribosomal protein S6 kinase pathway, caspase-3, Bax and the mammalian target of rapamycin (mTOR) [9].